Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chandrakala Shanmukhaiah
Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor
PLoS ONE
Multidisciplinary
Related publications
BCR-ABL Tyrosine Kinase
Science-Business eXchange
Differential Genomics and Transcriptomics Between Tyrosine Kinase Inhibitor-Sensitive and -Resistant BCR-ABL-dependent Chronic Myeloid Leukemia
Oncotarget
Oncology
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
Multidomain Targeting of BCR-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Effect of a Selective Abl Tyrosine Kinase Inhibitor, STI571, on in Vitro Growth of BCR-ABL-positive Acute Lymphoblastic Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Regulation of BCR-Abl-Induced SAP Kinase Activity and Transformation by the SHPTP1 Protein Tyrosine Phosphatase
Oncogene
Cancer Research
Genetics
Molecular Biology
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
